IdentificationGeneric Name(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDEDrugBank Accession NumberDB07290BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE (DB07290)× CloseWeightAverage: 346.374 Monoisotopic: 346.099870623 Chemical FormulaC14H19FN2O5SSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismULethal factorNot AvailableBacillus anthracisAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassBenzenesulfonamidesDirect ParentBenzenesulfonamidesAlternative ParentsAlpha amino acids and derivatives / Benzenesulfonyl compounds / Toluenes / Fluorobenzenes / Oxanes / Organosulfonamides / Aryl fluorides / Aminosulfonyl compounds / Hydroxamic acids / Oxacyclic compounds / Dialkyl ethers / Hydrocarbon derivatives / Carbonyl compounds / Organic oxides / Organofluorides / Organonitrogen compounds / Organopnictogen compounds


 show 7 moreSubstituentsAlpha-amino acid or derivatives / Aminosulfonyl compound / Aromatic heteromonocyclic compound / Aryl fluoride / Aryl halide / Benzenesulfonamide / Benzenesulfonyl group / Carbonyl group / Carboxylic acid derivative / Dialkyl ether / Ether / Fluorobenzene / Halobenzene / Hydrocarbon derivative / Hydroxamic acid / N-substituted-alpha-amino acid / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organic sulfonic acid or derivatives / Organofluoride / Organohalogen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Organosulfonic acid amide / Organosulfonic acid or derivatives / Organosulfur compound / Oxacycle / Oxane / Sulfonyl / Toluene


 show 23 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyLUCFRFDOOYLALP-CYBMUJFWSA-NInChIInChI=1S/C14H19FN2O5S/c1-9-8-11(2-3-12(9)15)23(20,21)17-13(14(18)16-19)10-4-6-22-7-5-10/h2-3,8,10,13,17,19H,4-7H2,1H3,(H,16,18)/t13-/m1/s1IUPAC Name(2R)-2-(4-fluoro-3-methylbenzenesulfonamido)-N-hydroxy-2-(oxan-4-yl)acetamideSMILES[H][C@@](NS(=O)(=O)C1=CC(C)=C(F)C=C1)(C1CCOCC1)C(=O)NOReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound4369384PubChem Substance99443761ChemSpider3571962BindingDB8503ChEMBLCHEMBL204593ZINCZINC000003818457PDBe Ligand915PDB Entries1yqyClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility1.16 mg/mLALOGPSlogP0.12ALOGPSlogP0.76ChemaxonlogS-2.5ALOGPSpKa (Strongest Acidic)8.68ChemaxonpKa (Strongest Basic)-4.1ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area104.73 Å2ChemaxonRotatable Bond Count4ChemaxonRefractivity81.08 m3·mol-1ChemaxonPolarizability32.84 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.7826Blood Brain Barrier-0.6963Caco-2 permeable-0.6156P-glycoprotein substrateSubstrate0.6174P-glycoprotein inhibitor INon-inhibitor0.5494P-glycoprotein inhibitor IINon-inhibitor0.9838Renal organic cation transporterNon-inhibitor0.9157CYP450 2C9 substrateNon-substrate0.6038CYP450 2D6 substrateNon-substrate0.8053CYP450 3A4 substrateNon-substrate0.5588CYP450 1A2 substrateNon-inhibitor0.775CYP450 2C9 inhibitorNon-inhibitor0.6427CYP450 2D6 inhibitorNon-inhibitor0.8762CYP450 2C19 inhibitorNon-inhibitor0.5772CYP450 3A4 inhibitorNon-inhibitor0.7271CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8092Ames testNon AMES toxic0.6022CarcinogenicityNon-carcinogens0.8001BiodegradationNot ready biodegradable1.0Rat acute toxicity2.5334 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9684hERG inhibition (predictor II)Inhibitor0.5  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)54722A30832


 Details


 Binding Properties1. Lethal factorKindProteinOrganismBacillus anthracisPharmacological actionUnknownGeneral FunctionMetallopeptidase activitySpecific FunctionOne of the three proteins composing the anthrax toxin, the agent which infects many mammalian species and that may cause death. LF is the lethal factor that, when associated with PA, causes death. ...Gene NamelefUniprot IDP15917Uniprot NameLethal factorMolecular Weight93769.58 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:20 / Updated at June 12, 2020 16:52 